These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 24795128)
1. Usefulness of genetic diagnosis in a woman with hypertrophic cardiomyopathy and the desire for motherhood. Villacorta E; Zatarain-Nicolás E; Fernández-Pena L; Pérez-Milán F; Sánchez PL; Fernández-Avilés F Rev Esp Cardiol (Engl Ed); 2014 Feb; 67(2):148-50. PubMed ID: 24795128 [No Abstract] [Full Text] [Related]
2. Usefulness of genetic diagnosis in a woman with hypertrophic cardiomyopathy and the desire for motherhood: information is key. Barriales-Villa R; García-Giustiniani DA; Ortiz-Genga M; Monserrat L Rev Esp Cardiol (Engl Ed); 2014 Apr; 67(4):333-4. PubMed ID: 24774605 [No Abstract] [Full Text] [Related]
3. Usefulness of genetic diagnosis in a woman with hypertrophic cardiomyopathy and the desire for motherhood: information is key. Response. Villacorta E; Zatarain-Nicolás E; Sánchez PL; Fernández-Avilés F Rev Esp Cardiol (Engl Ed); 2014 Apr; 67(4):334. PubMed ID: 24774606 [No Abstract] [Full Text] [Related]
4. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. Maron BJ; Maron MS; Semsarian C J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258 [TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy--beyond the sarcomere. St John Sutton M; Epstein JA N Engl J Med; 1998 Apr; 338(18):1303-4. PubMed ID: 9562586 [No Abstract] [Full Text] [Related]
6. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Christiaans I; Birnie E; Bonsel GJ; Wilde AA; van Langen IM Eur J Hum Genet; 2008 Oct; 16(10):1201-7. PubMed ID: 18478037 [TBL] [Abstract][Full Text] [Related]
7. Genetic Testing and Counseling for Hypertrophic Cardiomyopathy. Cirino AL; Seidman CE; Ho CY Cardiol Clin; 2019 Feb; 37(1):35-43. PubMed ID: 30447714 [TBL] [Abstract][Full Text] [Related]
8. Guidelines for the diagnosis and management of hypertrophic cardiomyopathy. Semsarian C; Heart Lung Circ; 2007 Feb; 16(1):16-8. PubMed ID: 17188934 [No Abstract] [Full Text] [Related]
9. The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain). Reguero JR; Gómez J; Martín M; Flórez JP; Morís C; Iglesias S; Alonso B; Alvarez V; Coto E Int J Cardiol; 2013 Oct; 168(4):4555-6. PubMed ID: 23870641 [No Abstract] [Full Text] [Related]
10. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C]. García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878 [TBL] [Abstract][Full Text] [Related]
11. The Gln1233ter mutation of the myosin binding protein C gene: causative mutation or innocent polymorphism in patients with hypertrophic cardiomyopathy? Tóth T; Nagy V; Faludi R; Csanády M; Nemes A; Simor T; Forster T; Sepp R Int J Cardiol; 2011 Dec; 153(2):216-9. PubMed ID: 21985754 [No Abstract] [Full Text] [Related]
12. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting. Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739 [TBL] [Abstract][Full Text] [Related]
13. [The contribution of molecular genetics to clinical cardiology: the example of hypertrophic cardiomyopathy]. Fokstuen S; Blouin JL; Lyle R; Lerch R; Beghetti M; Mach F; Sztajzel J; Antonarakis SE; Sigwart U Rev Med Suisse; 2005 May; 1(21):1448, 1450, 1452-3. PubMed ID: 15997984 [TBL] [Abstract][Full Text] [Related]
14. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy. Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860 [TBL] [Abstract][Full Text] [Related]
16. Cardiac myosin-binding protein C gene mutation expressed as hypertrophic cardiomyopathy and left ventricular noncompaction within two families: insights from cardiac magnetic resonance in clinical screening: Camuglia MYBPC3 gene mutation and MRI. Camuglia AC; Younger JF; McGaughran J; Lo A; Atherton JJ Int J Cardiol; 2013 Oct; 168(3):2950-2. PubMed ID: 23642604 [No Abstract] [Full Text] [Related]
17. The enigmatic diversity of hypertrophic cardiomyopathy. Brito D Rev Port Cardiol; 2005 Dec; 24(12):1479-84. PubMed ID: 16566406 [No Abstract] [Full Text] [Related]
18. Genetic investigation and counselling of families with hypertrophic cardiomyopathy. Davies MJ; Krikler DM Br Heart J; 1994 Aug; 72(2):99-101. PubMed ID: 7917706 [No Abstract] [Full Text] [Related]
19. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death. Chung WK; Kitner C; Maron BJ Cardiol Young; 2011 Jun; 21(3):345-8. PubMed ID: 21262074 [TBL] [Abstract][Full Text] [Related]
20. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]